Impact of a National β-Thalassemia Carrier Screening Program on the birth rate of thalassemia major

Pediatric Blood and Cancer

Volumn 46, Issue 1, 2006, Pages 72-76

  Chern, Jimmy P S ^a,d   Lin, Kai Hsin ^b   Su, Yi Ning ^b   Lu, Meng Yao ^b   Jou, Shiann Tarng ^b   Lin, Dong Tsamn ^b   Wang, Shih Chung ^c   Lin, Kuo Sin ^b  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anemia; Beta thalassemia major; Colley's; Epidemiology; Hematology; Hemoglobinopathies

Indexed keywords

DNA; FERRITIN; GENOMIC DNA; HEMOGLOBIN A2; HEMOGLOBIN E; HEMOGLOBIN F; IRON;

ALGORITHM; AMNION FLUID; ANEMIA; ARTICLE; BETA THALASSEMIA; BLOOD CELL COUNT; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CHORION VILLUS SAMPLING; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIET SUPPLEMENTATION; DISEASE CARRIER; DISEASE SEVERITY; DNA DETERMINATION; FERRITIN BLOOD LEVEL; FETUS BLOOD; GENE MUTATION; HEALTH PROGRAM; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; SCREENING TEST; TAIWAN; THALASSEMIA MAJOR;

BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; INFANT; INFANT, NEWBORN; MUTATION; NATIONAL HEALTH PROGRAMS; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; PROGRAM EVALUATION; TAIWAN;

EID: 28844436085     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20343     Document Type: Article

References (22)

1. Weatherall DJ. Single gene disorders or complex traits: Lessons from the thalassaemias and other monogenic diseases. BMJ 2000;321:1117-1120.
2. Winichagoon P, Fucharoen S, Chen P, et al. Genetic factors affecting clinical severity in beta-thalassemia syndromes. J Pediatr Hematol Oncol 2000;22:573-580.
3. Ko TM, Hsu PM, Chen CJ, et al. Incidence study of heterozygous [beta]-thalassemia in northern Taiwan. J Formos Med Assoc 1989;88:678-681.
4. Lin KH, Lin LL, Su S, et al. The incidence of [beta]-thalassemia trait in Taiwan. Int J Pediatr Hematol Oncol 1994;1:383-388.
5. Cao A, Rosatelli MC, Galanello R. Population-based genetic screening. Curr Opin Genet Dev 1991;1:48-53.
6. Loukopoulos D. Current status of thalassemia and the sickle cell syndromes in Greece. Semin Hematol 1996;33:76-86.
7. Angastiniotis MA, Hadjiminas MG. Prevention of thalassaemia in Cyprus. Lancet 1981;1:369-371.
8. Ko TM, Xu X. Molecular study and prenatal diagnosis of [alpha]- and [beta]- thalassemia in Chinese. J Formos Med Assoc 1998;97:5-15.
9. Ho PJ, Hall GW, Luo LY, et al. Beta-thalassaemia intermedia: Is it possible consistently to predict phenotype from genotype? Br J Haematol 1998;100:70-78.
10. Su YN, Lee CN, Hung CC, et al. Rapid detection of beta-globin gene (HBB) mutations coupling heteroduplex and primer-extension analysis by DHPLC. Hum Mutat 2003;22:326-336.
11. Health and vital statistics, Republic of China. 2002. http:// www.moi.gov.tw/W3/stat/english/index.htm
12. Ko TM, Hsieh FJ, Chen CJ, et al. Cord blood screening for alpha-thalassemia in northern Taiwan. J Formos Med Asso 1988;87:146-149.
13. Lin KH, Lin KS. Results of therapy for beta-thalassemia major. J Formos Med Assoc 1992;91:126-130.
14. Olivieri NF. The beta-thalassemias. N Engl J Med 1999;341:99-109.
15. Streetly A. A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom. Questions are left after two evidence based reports. BMJ 2000;320:1353-1354.
16. Streetly A, Maxwell K, Campbell B. Coordinated neonatal screening programme for haemoglobin disorders is needed. BMJ 1998;316:937.
17. Ko TM, Tseng LH, Hsu PM, et al. Molecular characterization of beta-thalassemia in Taiwan and the identification of two new mutations. Hemoglobin 1997;21;131-142.
18. Cao A, Galanello R, Rosatelli MC. Prenatal diagnosis and screening of the haemoglobinopathies. Baillieres Clin Haematol 1998;11:215-238.
19. Modell B, Harris R, Lane B, et al. Informed choice in genetic screening for thalassaemia during pregnancy: Audit from a national confidential inquiry. BMJ 2000;320:337-341.
20. Harris R. How well do we manage families with genetic problems? A national confidential enquiry into counseling for genetic disorders should tell us. BMJ 1991;303:1412-1413.
21. Modell B, Khan M, Darlison M, et al. A national register for surveillance of inherited disorders: Beta thalassaemia in the United Kingdom. Bull World Health Organ 2001;79:1006-1013.
22. Modell M, Wonke B, Anionwu E, et al. A multidisciplinary approach for improving services in primary care: Randomised controlled trial of screening for haemoglobin disorders. BMJ 1998;317:788-791.